Green Forge can simulate heat waves, cold snaps, and varying humidity indoors to screen GM crops before costly field trials.
MOHALI: Union Minister Dr. Jitendra Singh inaugurated the “Green Forge” Complex at BRIC-National Agri-Food & Biomanufacturing Institute on August 31, describing it as a first-of-its-kind facility equipped with controlled simulation chambers for testing genetically modified crops under varied environmental conditions. The launch coincided with the National Conclave on BioE3 at the institute’s Mohali campus.
The core problem Green Forge addresses is deceptively simple: once a new GM crop variety exists in the lab, researchers still need to figure out exactly where in India’s diverse agro-climatic landscape it will actually thrive, a question traditionally answered only through expensive, time-consuming multi-location field trials.
Recreating Climates Indoors
Green Forge’s simulation chambers can independently modulate light quantity and spectral quality, temperature, including simulated heat waves and cold snaps and humidity, from arid to tropical conditions. Sensors inside the chambers track growth rates, leaf canopy temperature, stomatal responses and biomass accumulation, feeding this data into machine learning models that correlate plant performance under synthetic stress with real agro-climatic data across India’s regions. In effect, researchers can identify likely failure points and target growing zones before ever planting a single seed in open soil.
Singh noted the facility’s cross-domain potential extends beyond food crops into plant-made pharmaceuticals and high-value secondary metabolites, though official disclosures have not detailed specifics like containment certification levels, exact chamber dimensions, or how many plant lines can be processed concurrently.
Part of a Much Larger Biomanufacturing Push
Green Forge sits within India’s BioE3 Policy, approved by the Union Cabinet in August 2024, and connects to a nationwide network of 21 or 22 biomanufacturing hubs alongside eight dedicated biofoundries spanning institutions from ICGEB in New Delhi to NCCS in Pune. These facilities cover everything from mRNA biologics at Gennova Biopharmaceuticals to industrial carbon capture at Jindal Steel’s Angul plant, reflecting the government’s ambition to grow India’s bioeconomy from $10 billion in 2014 to a targeted $300 billion by 2030, up from over $165 billion currently. A User Access Policy notified in August 2025 is meant to ensure startups and academic researchers alike can book time on this capital-intensive infrastructure, though the granular scheduling and fee mechanics remain unpublished.
What Green Forge Is Not
It’s important to be precise about what this inauguration actually changes. Green Forge operates strictly within the first of three regulatory stages governing GM crops in India. Contained research inside the facility falls under the Review Committee on Genetic Manipulation within the Department of Biotechnology. Any promising crop line must still clear the Genetic Engineering Appraisal Committee, housed in the environment ministry, for open-air confined field trials, and separately secure location-specific no-objection certificates from individual state governments before those trials can even begin. Commercial cultivation requires a further round of GEAC environmental release clearance and FSSAI food safety authorization. Green Forge accelerates and de-risks the earliest stage of this pipeline; it does not shorten or bypass any of the statutory steps that follow.
Why the Early Screening Matters
The scientific rationale is grounded in a well-documented problem: genotype-by-environment interactions, where the same genetic modification can perform unpredictably depending on local heat, light and water conditions. Historically, catching these instabilities required planting across multiple physical sites over several growing seasons, a costly and slow process particularly burdensome for public research institutes and smaller biotech startups. By exposing young transgenic plants to synthetic stress conditions early, Green Forge lets researchers weed out underperforming genetic events before committing to expensive field trials, theoretically improving the success rate and speed of India’s crop development pipeline.
The Limits of Simulation
Indoor chambers, however capable, cannot fully replicate the biotic complexity of open fields, soil microbiome variation, localized pest pressure, and fungal dynamics all remain outside what controlled simulation can capture. How well chamber performance actually predicts real-world field outcomes is an empirical question that will need validation across different crop species over time, and the public record offers no data yet on this correlation.
Unresolved Questions
Several practical and policy issues remain open. The proportional split of chamber access between academic institutions and private startups isn’t yet detailed, nor are the intellectual property rules governing datasets generated when private companies run trials using AI models trained on public facility data. Perhaps most significantly, accelerating contained research does not resolve the downstream bottleneck of state-level NOC approvals, a process that has historically delayed GEAC-cleared trials regardless of how quickly candidates move through earlier research stages.
What to Track
Meaningful signals of Green Forge’s real-world impact will emerge from a handful of measurable indicators: the number of GM crop candidates that successfully progress from chamber testing to formal RCGM or GEAC trial applications, chamber utilisation rates split between academic and startup users, patents and publications originating from the facility, and the pace at which predictive AI models get validated across India’s different agro-ecological zones. Until those numbers start accumulating, Green Forge remains a promising infrastructure upgrade whose actual translational impact on India’s GM crop pipeline is still to be demonstrated.
About the Author
